We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Sentinel Diagnostics

Sentinel Diagnostics develops and manufactures in-vitro diagnostic medical devices for routine analysis and specific ... read more Featured Products: More products

Download Mobile App





Sentinel Diagnostics Presents New Fully Automated Sample to Result System for Diagnosis of Viral Infections

By LabMedica International staff writers
Posted on 15 Nov 2022

Sentinel Diagnostics (Milano, Italy) is presenting its newly-launched SENTiNAT 200 fully automated sample to result system, and STAT-NAT SN200 Real-Time PCR assays for the quantitative detection of 10 viruses at MEDICA 2022. More...

The new SENTiNAT 200 and STAT-NAT SN200 kits represent the ideal solution for mid to large throughput laboratories engaged in the diagnosis of viral infections.

SENTiNAT 200 is a compact platform for DNA/RNA extraction, PCR set up and amplification that includes two integrated thermal cyclers and the FastFinder analysis software. The system combines throughput, automation and flexibility to better adapt to the various laboratory needs. It performs multi-parametric analysis of up to 15 viruses in the same run, processing from one up to 48 samples in four hours. The intuitive software that guides the operator through all the phases of the instrument set up, along with the barcode reader for samples and reagents help to reduce human error. The operator can access to the data available on the cloud anytime anywhere, to optimize reporting time while maintaining full control over the results.

SENTiNAT 200 is designed to work with STAT-NAT SN200 kits, based on the freeze-dried patented technology that allows long term stability at room temperature, making the assays more robust and simplifying reagent management in the laboratory. Also on display at the Sentinel booth at MEDICA 2022 is the recently launched SENTiFIT 800 high-throughput and fully automated solution for fecal immunochemical tests. SENTiFIT 800 represents the solution to help laboratories in the diagnosis of CRC as well as other digestive diseases.

“We developed the SENTiNAT 200 and STAT-NAT SN200 kits, all CE-marked, to offer a complete solution, that simplifies the routine activities of virology laboratories, including those dedicated to transplant patient,” said Marco Buonaguidi, Head of Sales and Marketing. “Today, we take a first step on a path that will see us committed to developing new parameters to satisfy the most challenging requests of our clients in molecular diagnostics.”

Related Links:
Sentinel Diagnostics 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Portable POCT Blood Gas Analyzer
BD100
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.